Pablo G. Legorreta
CEO, Chairman of the Board at Royalty Pharma plc
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Royalty Pharma plc, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Royalty Pharma plc June 4, 202694.0%
-
ProKidney Corp. May 29, 202599.2%
-
Royalty Pharma plc May 12, 202595.0%
-
Royalty Pharma plc June 6, 202496.6%
-
Royalty Pharma plc June 22, 202398.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 4, 2026 | Royalty Pharma plc | Grant or award | +42,209 | — | — |
| Aug 5, 2026 | Royalty Pharma plc | Grant or award | +65,216 | — | — |
| May 6, 2026 | Royalty Pharma plc | Grant or award | +143,821 | — | — |
| Feb 11, 2026 | Royalty Pharma plc | Grant or award | +157,828 | — | — |
| Nov 5, 2025 | Royalty Pharma plc | Grant or award | +36,559 | — | — |
| Aug 6, 2025 | Royalty Pharma plc | Grant or award | +21,901 | — | — |
| Jun 3, 2025 | ProKidney Corp. | Derivative conversion | +3,823,996 | — | — |
| Jun 3, 2025 | ProKidney Corp. | Other | −3,823,996 | — | — |
| May 16, 2025 | Royalty Pharma plc | Other | +530,348 | — | — |
| May 8, 2025 | Royalty Pharma plc | Grant or award | +288,352 | — | — |
| Feb 4, 2025 | ProKidney Corp. | Derivative conversion | +532,535 | — | — |
| Feb 4, 2025 | ProKidney Corp. | Other | −532,535 | — | — |
| Jun 13, 2024 | ProKidney Corp. | Open-market purchase | +22,617,909 | $2.42 | $54,735,340 |
| Feb 5, 2024 | ProKidney Corp. | Derivative conversion | +748,952 | — | — |
| Feb 5, 2024 | ProKidney Corp. | Other | −748,952 | — | — |
Questions about Pablo G. Legorreta
What boards is Pablo G. Legorreta on?
Pablo G. Legorreta sits on the boards of ProKidney Corp. and Royalty Pharma plc.
What company is Pablo G. Legorreta the CEO of?
Pablo G. Legorreta is CEO, Chairman of the Board of Royalty Pharma plc.
How long has Pablo G. Legorreta served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.